[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 1968

Epinephrine Maculopathy

Arch Ophthalmol. 1968;79(5):552-562. doi:10.1001/archopht.1968.03850040554010

The clinical features of a maculopathy related to the use of topical epinephrine in 22 eyes of 15 patients are presented. Visual loss varied from 20/40 to less than 20/400, and was reversible in all but one instance when the drug was withdrawn. All patients, except one, were aphakic. In the one phakic case the lens was completely dislocated into the vitreous. The incidence of the maculopathy appears to be at least 20% to 30% in aphakic eyes treated with epinephrine. It varies with the concentration of epinephrine used, may appear within a few weeks or many months after epinephrine therapy is begun, and is reproducible on administration of topical epinephrine to the same patient.